HIV 1 News and Research

RSS

New treatment may destroy HIV's last refuge

UK scientists may have found a way to destroy HIV's last refuge. A study by Oxford University has confirmed that a treatment developed by a British company can remove the virus in its chosen hiding place, in laboratory conditions, offering hope of a viable treatment.

15 Jul 2016

Research highlights global burden of HIV and other infectious diseases among prisoners and detainees

Prisoners and detainees worldwide have higher burdens of HIV, viral hepatitis and tuberculosis than the communities from which they come, and the regular cycling of infected people in and out of incarceration is worsening the epidemics both inside and outside of prison, new Johns Hopkins Bloomberg School of Public Health-led research suggests.

15 Jul 2016

New Global Fund report shows significant increase in HIV treatment

Ahead of next week’s International AIDS Conference in Durban, South Africa, the Global Fund to Fight AIDS, Tuberculosis and Malaria today released results that show a significant increase in the number of people being treated for HIV.

14 Jul 2016

The Wistar Institute and partners receive HIV cure research grant to test novel immunotherapies

The Wistar Institute is pleased to announce that the National Institutes of Health has awarded a nearly $23 million Martin Delaney Collaboratories for HIV Cure Research grant to the BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy, a consortium of top HIV researchers led by co-principal investigators Luis J. Montaner, D.V.M., D.Phil., director of the HIV-1 Immunopathogenesis Laboratory at The Wistar Institute Vaccine Center, and James L. Riley, Ph.D., research associate professor at the Perelman School of Medicine at the University of Pennsylvania.

13 Jul 2016

Researchers receive grant to test transcutaneously refillable implant that delivers HIV-prevention drugs

A Houston Methodist research team received a nearly $4 million grant to test a transcutaneously refillable implant that administers pre-exposure prophylaxis drugs to subjects at risk of HIV-exposure.

13 Jul 2016

Community-level ART coverage, male circumcision linked to decline in new male HIV infections in Uganda

Increasing the number of men who undergo circumcision and increasing the rates at which women with HIV are given antiretroviral therapy (ART) were associated with significant declines in the number of new male HIV infections in rural Ugandan communities, new Johns Hopkins Bloomberg School of Health research suggests.

13 Jul 2016

Sugar-binding protein galectin-9 could be new weapon to fight HIV

The ultimate impediment to a cure for HIV infection is the presence of latent, HIV-infected cells, which can reawaken and produce new virus when antiretroviral drug therapy is stopped.

13 Jul 2016

New study finds whether HIV-infected people on antiretroviral treatment transmit virus to their partner

A new study has found that neither gay men nor heterosexual people with HIV transmit the virus to their partner, provided they are on suppressive antiretroviral treatment.

13 Jul 2016

Grindr app could be effective way to distribute HIV self-testing kits to high-risk men who have sex with men

A study led by researchers from UCLA found that the gay social and sexual networking app Grindr is an effective means through which to distribute HIV self-testing kits among men who have sex with men who have a high risk for contracting the virus.

13 Jul 2016

Study results pave way to development of effective human vaccine against HIV

A new scientific study conducted by a team of leading AIDS scientists reveal results that lead the way to the development of an effective human vaccine against human immunodeficiency virus (HIV).

8 Jul 2016

Study highlights ongoing global epidemic of HIV among gay men

Gay, bisexual and other men who have sex with men continue to have disproportionately high burdens of HIV infection in countries of low, middle and high income around the world, a new study led by the Johns Hopkins Bloomberg School of Public Health suggests.

8 Jul 2016

WRAIR collaborates with Sanofi Pasteur to develop ZPIV vaccine candidate

The Walter Reed Army Institute of Research announces a Cooperative Research and Development Agreement for the development of a Zika vaccine candidate with Sanofi Pasteur, the vaccines division of Sanofi.

7 Jul 2016

Study reveals high healthcare costs for chronic pain patients in Canada

Costs of patients who develop chronic post-surgical pain could range from $2.5 million to $4.1 million a year, in one Ontario hospital alone, according to a study in Pain Management.

6 Jul 2016

Researchers find distinct, non-identical differences among retroviruses

In the most comprehensive study of its kind, researchers in the report that most types of retroviruses have distinct, non-identical virus structures.

6 Jul 2016

Implementation science may help prevent mother-to-child HIV transmissions

An emerging field, known as implementation science, may help reduce the nearly 150,000 instances of mother-to-child HIV transmissions that occur annually around the world, mostly in developing countries. c

1 Jul 2016

Experts compile model list of essential diagnostic tests aiming to improve global health

In a western doctor's office or hospital, patients don't think twice about giving a blood or urine sample that can tell if they have a disease or infection, or show if their medicines are working. The samples get rushed to a testing lab with modern equipment that's held to high quality standards.

30 Jun 2016

TSRI scientists develop new strategy to design potential HIV vaccine candidates

Want to catch a criminal? Show a mugshot on the news. Want to stop HIV infections? Get the immune system to recognize and attack the virus's tell-tale structure. That's part of the basic approach behind efforts at The Scripps Research Institute to design an AIDS vaccine.

29 Jun 2016

Experts receive NIH grant to study why some HIV-infected individuals resist TB

Case Western Reserve University School of Medicine experts and colleagues in the United States and Africa have received an $11 million, five-year NIH grant to understand why some people living with HIV in Africa avoid becoming infected with the bacterium that causes tuberculosis (TB) despite exposure to high-TB-risk circumstances.

29 Jun 2016

Tiny doses of anti-HIV drug may be effective for treating Alzheimer's disease

For a promising pathway to treating Alzheimer's patients, "aim here." That's what National Institute of Standards of Technology researchers advised collaborators hunting for molecules that, by linking to a normally occurring enzyme, rev up the brain's capacity for clearing cholesterol--a boost associated with improvements in memory and other benefits in animal studies.

29 Jun 2016

Strengthening immune defence system may provide treatment alternative for tuberculosis

Researchers at Linköping University have made a discovery that could contribute to developing new vaccines and treatment alternatives for tuberculosis in the future. The results have been published in Scientific Reports, a sister journal to the highly respected periodical Nature.

27 Jun 2016

HIV 1 News and Research

New treatment may destroy HIV's last refuge

Research highlights global burden of HIV and other infectious diseases among prisoners and detainees

New Global Fund report shows significant increase in HIV treatment

The Wistar Institute and partners receive HIV cure research grant to test novel immunotherapies

Researchers receive grant to test transcutaneously refillable implant that delivers HIV-prevention drugs

Community-level ART coverage, male circumcision linked to decline in new male HIV infections in Uganda

Sugar-binding protein galectin-9 could be new weapon to fight HIV

New study finds whether HIV-infected people on antiretroviral treatment transmit virus to their partner

Grindr app could be effective way to distribute HIV self-testing kits to high-risk men who have sex with men

Study results pave way to development of effective human vaccine against HIV

Study highlights ongoing global epidemic of HIV among gay men

WRAIR collaborates with Sanofi Pasteur to develop ZPIV vaccine candidate

Study reveals high healthcare costs for chronic pain patients in Canada

Researchers find distinct, non-identical differences among retroviruses

Implementation science may help prevent mother-to-child HIV transmissions

Experts compile model list of essential diagnostic tests aiming to improve global health

TSRI scientists develop new strategy to design potential HIV vaccine candidates

Experts receive NIH grant to study why some HIV-infected individuals resist TB

Tiny doses of anti-HIV drug may be effective for treating Alzheimer's disease

Strengthening immune defence system may provide treatment alternative for tuberculosis

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News